Related Experiment Video
Updated: May 13, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
A review of central retinal artery occlusion: clinical presentation and management
1Flinders Comprehensive Stroke Centre, Flinders Medical Centre and Flinders University, Adelaide, South Australia, Australia.
Abstract:
Central retinal artery occlusion (CRAO) is an ophthalmic emergency and the ocular analogue of cerebral stroke. Best evidence reflects that over three-quarters of patients suffer profound acute visual loss with a visual acuity of 20/400 or worse. This results in a reduced functional capacity and quality of life. There is also an increased risk of subsequent cerebral stroke and ischaemic heart disease. There are no current guideline-endorsed therapies, although the use of tissue plasminogen activator (tPA) has been investigated in two randomized controlled trials. This review will describe the pathophysiology, epidemiology, and clinical features of CRAO, and discuss current and future treatments, including the use of tPA in further clinical trials.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Glaucoma: Overview
Diabetic Retinopathy
Aneurysm II: Clinical Manifestations and Diagnostic Studies